Eisai
4523.T
#2014
Rank
A$12.61 B
Marketcap
$44.76
Share price
0.87%
Change (1 day)
-29.68%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2023 (TTM): $3.26

According to Eisai's latest financial reports the company's current EPS (TTM) is $3.42. In 2022 the company made an earnings per share (EPS) of $2.51 a decrease over its 2021 EPS that were of $11.14.

EPS history for Eisai from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$3.2629.87%
2022$2.51-77.48%
2021$11.14-41.88%
2020$19.17-0.94%
2019$19.3552.59%
2018$12.68124.17%
2017$5.66-49.42%
2016$11.1937.08%
2015$8.16-11.75%
2014$9.25-3.23%
2013$9.55-18.56%
2012$11.73-15.51%
2011$13.89-3.75%
2010$14.43-1.36%
2009$14.63